BIDU vs ZVRA · rev $18.46B vs P/E 6.3, rev $75.9M
Baidu Inc (BIDU) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Baidu Inc (BIDU) is a internet content & information company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported BIDU revenue for 2025-12-31 was $18.46B. Net income was $799.0M. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. BIDU currently screens at market cap $37.98B.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
BIDU currently screens at market cap $37.98B. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the BIDU and ZVRA stock pages for the full models.
Not investment advice.